Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Adenocarcinoma
Stauffer, John , Coppola, Alessandro , Mody, Kabir , Asbun, Horacio J. , A Stauffer, John

World Journal of Surgery | February 3, 2016 | Volume: 40 | Issue: 6 | Pages: 1477-1484

10.1007/s00268-016-3412-6 | PMID 26847665 Get It

AbstractBackgroundLaparoscopic distal pancreatectomy (LDP) has been shown to have short‐term benefits over open distal pancreatectomy (ODP). Its application for pancreatic ductal adenocarcinoma (PDAC) remains controversial.MethodsFrom 1995 to 2014, 72 patients underwent distal pancreatectomy for PDAC at a single institution and were included in the study. Postoperative and long‐term outcomes of patients undergoing LDP (n = 44) or ODP (n = 28) were compared.ResultsLDP was associated with less blood loss (332 vs. 874 mL, p = 0.0012) and lower transfusion rates than ODP (18.2 vs. 50 %, p = 0.0495). Operative time was similar (254 vs. 266 min) for LDP and ODP; five patients (11.4 %) required conversion to ODP. Pancreatic fistulas (13.6 vs. 7.1 %) and major complications (13.6 vs. 25 %), were similar between LDP and ODP, respectively. Length of hospital stay (5.1 vs. 9.4 days, p = 0.0001) and time to initiate adjuvant therapy (69.4 vs. 95.6 days, p = 0.0441) was shorter for LDP than ODP. Tumor characteristics were similar but LDP was associated with more resected lymph nodes than ODP (25.9 vs. 12.7, p = 0.0001). One‐, three‐, and five‐year survival rates were similar between LDP (69, 41, and 41 %, respectively) and ODP (78, 44, and 32 %, respectively).ConclusionLDP is associated with less blood loss and need for blood transfusion, shorter hospital stay, and faster time to initiate adjuvant therapy than ODP for patients with PDAC. Postoperative outcomes and long‐term survival are similar between the two groups. LDP appears to be safe in the treatment of patients with PDAC.
Rasburicase‐induced methemoglobinemia: case report, literature review, and proposed treatment algorithm
Sherwood, Garrett, Paschal, Rita, Adamski, Jill

Clinical Case Reports | February 3, 2016 | Volume: 4 | Issue: 4 | Pages: 315-319

10.1002/ccr3.495 | PMID 27099716 Get It

Key Clinical MessageRasburicase for the treatment of tumor lysis syndrome has been associated with hemolytic anemia and methemoglobinemia, usually in patients with G6PD deficiency. Risks and benefits should be considered prior to use of rasburicase in at‐risk patients. Methylene blue will worsen the hemolytic anemia in G6PD deficiency and should be avoided.
Helping African Americans of Faith Embrace End-of-Life Discussions
Robinson, Maisha T.

Journal of Palliative Medicine | February 3, 2016 | Volume: 19 | Issue: 2 | Pages: 235-236

10.1089/jpm.2015.0321 | PMID 26840861 Get It

Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C
Koga, Shunsuke , Josephs, Keith A. , Ogaki, Kotaro, Uitti, Ryan J. , Graff‐Radford, Neill R. , Gerpen, Jay A. van, Cheshire, William P. , Aoki, Naoya , Rademakers, Rosa , Ross, Owen A. , Labbé, Catherine, Van Gerpen, Jay A, Labbé, Catherine , Wszołek, Zbigniew K. , Dickson, Dennis W. , Koga, Shunsuke , Cheshire, William P , Ross, Owen A

Movement Disorders | February 3, 2016 | Volume: 31 | Issue: 5 | Pages: 653-662

10.1002/mds.26499 | PMID 26841329 Get It

ABSTRACTBackgroundCerebellar ataxia is an exclusion criterion for the clinical diagnosis of progressive supranuclear palsy, but a variant with predominant cerebellar ataxia has been reported. The aims of this study were to estimate the frequency of progressive supranuclear palsy with predominant cerebellar ataxia in an autopsy series from the United States and to compare clinical, pathologic, and genetic differences between progressive supranuclear palsy with and without predominant cerebellar ataxia.MethodWe selected 100 consecutive patients with pathologically confirmed progressive supranuclear palsy who had been evaluated at the Mayo Clinic (referred to as the Mayo Clinic patient series) from our brain bank database (N = 1085). We next enriched in cases likely to have cerebellar ataxia by searching the remaining 985 cases for (1) an antemortem diagnosis of multiple system atrophy or (2) neuropathologic evidence of prominent degeneration of the cerebellum or cerebellar afferent nuclei. Subsequently, clinical, pathologic, and genetic features were compared between the two groups.ResultsOne patient in the Mayo Clinic patient series (1%) met criteria for progressive supranuclear palsy with predominant cerebellar ataxia and had both cerebellar and mild midbrain atrophy on MRI. Four patients were identified with the targeted search. Four of the five patients were clinically misdiagnosed as multiple system atrophy. The severity of tau‐related pathology and cerebellar degeneration were not different between the two groups. No differences were detected in tau genotypes.ConclusionAlthough our data cannot provide definitive information about how to make an accurate clinical diagnosis, they should serve to raise awareness of progressive supranuclear palsy with predominant cerebellar ataxia in the differential diagnosis of multiple system atrophy. © 2016 Movement Disorder Society
Protein Kinase D Enzymes as Regulators of EMT and Cancer Cell Invasion
Durand, Nisha , Borgés, Sahra, Störz, Peter

Journal of Clinical Medicine | February 3, 2016 | Volume: 5 | Issue: 2 | Pages: 20

10.3390/jcm5020020 | PMID 26848698 Get It

The Protein Kinase D (PKD) isoforms PKD1, PKD2, and PKD3 are effectors of the novel Protein Kinase Cs (nPKCs) and diacylglycerol (DAG). PKDs impact diverse biological processes like protein transport, cell migration, proliferation, epithelial to mesenchymal transition (EMT) and apoptosis. PKDs however, have distinct effects on these functions. While PKD1 blocks EMT and cell migration, PKD2 and PKD3 tend to drive both processes. Given the importance of EMT and cell migration to the initiation and progression of various malignancies, abnormal expression of PKDs has been reported in multiple types of cancers, including breast, pancreatic and prostate cancer. In this review, we discuss how EMT and cell migration are regulated by PKD isoforms and the significance of this regulation in the context of cancer development.
Consequences Validity Evidence: Evaluating the Impact of Educational Assessments
Cook, David A. , Lineberry, Matthew , Lineberry, Matt

Academic Medicine | February 3, 2016 | Volume: 91 | Issue: 6 | Pages: 785-795

10.1097/acm.0000000000001114 | PMID 26839945 Get It

Because tests that do not alter management (i.e., influence decisions and actions) should not be performed, data on the consequences of assessment constitute a critical source of validity evidence. Consequences validity evidence is challenging for many educators to understand, perhaps because it has no counterpart in the older framework of content, criterion, and construct validity. The authors’ purpose is to explain consequences validity evidence and propose a framework for organizing its collection and interpretation. Both clinical and educational assessments can be viewed as interventions. The act of administering or taking a test, the interpretation of scores, and the ensuing decisions and actions influence those being assessed (e.g., patients or students) and other people and systems (e.g., physicians, teachers, hospitals, schools). Consequences validity evidence examines such impacts of assessments. Despite its importance, consequences evidence is reported infrequently in health professions education (range 5%–20% of studies in recent systematic reviews) and is typically limited in scope and rigor. Consequences validity evidence can derive from evaluations of the impact on examinees, educators, schools, or the end target of practice (e.g., patients or health care systems); and the downstream impact of classifications (e.g., different score cut points and labels). Impact can result from the uses of scores or from the assessment activity itself, and can be intended or unintended and beneficial or harmful. Both quantitative and qualitative research methods are useful. The type, quantity, and rigor of consequences evidence required will vary depending on the assessment and the claims for its use.
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Kenderian, Saad S. , Macon, William R. , Ristow, Kay M., Ansell, Stephen M. , Johnston, Patrick B. , Inwards, David J. , Micallef, Ivana N. , Thompson, Carrie A. , Porrata, Luis F. , Martenson, James A., Nowakowski, Grzegorz S. , Kenderian, Saad Sirop , Habermann, Thomas M. , Colgan, Joseph P. , Markovic, Svetomir N. , Witzig, Thomas E.

Blood | February 2, 2016 | Volume: 127 | Issue: 16 | Pages: 1960-1966

10.1182/blood-2015-08-665505 | PMID 26837698 Get It

Key Points The risk of transformation of NLPHL to DLBCL is 0.74 per 100 patient-years of follow-up. Risk factors for transformation include prior exposure to chemotherapy and splenic involvement at time of diagnosis.
Unique cause of right hemispheric syndrome: Embolism of myocardium after open septal myectomy
Murphy, Meghan E. , Raghunathan, Aditya , Schaff, Hartzell V. , Fugate, Jennifer E. , Schaff, Hartzell, Lanzino, Giuseppe , Raghunathan, Aditya , Schaff, Hartzell

The Neuroradiology Journal | February 2, 2016 | Volume: 29 | Issue: 2 | Pages: 110-114

10.1177/1971400916628169 | PMID 26838173 Get It

We present a novel case of acute ischemic stroke in the postoperative setting of open septal myectomy. A 24-year-old woman developed acute left hemiparesis and rightward eye deviation the morning after surgery. She underwent emergent endovascular stoke therapy by mechanical embolectomy with successful retrieval of a fragment of myocardium that was obstructing the right middle cerebral artery. To our knowledge there has been no previous case described of a myocardial fragment causing a proximal intracranial artery occlusion with resulting ischemia and infarction.
Safety and Feasibility of Laparoscopic Abdominal Surgery in Patients With Mechanical Circulatory Assist Devices
Chapital, Alyssa B. , Johnson, Daniel J. , Staley, Linda L., Arabía, Francisco A. , Harold, Kristi L., Ashfaq, Awais , Ashfaq, Awais

Surgical Innovation | February 2, 2016 | Volume: 23 | Issue: 5 | Pages: 469-473

10.1177/1553350616628679 | PMID 26839214 Get It

Objectives. Increasing number of mechanical circulatory assist devices (MCADs) are being placed in heart failure patients. Morbidity from device placement is high and the outcome of patients who require noncardiac surgery after, is unclear. As laparoscopic interventions are associated with decreased morbidity, we examined the impact of such procedures in these patients. Methods. A retrospective review was conducted on 302 patients who underwent MCAD placement from 2005 to 2012. All laparoscopic abdominal surgeries were included and impact on postoperative morbidity and mortality studied. Results. Ten out of 16 procedures were laparoscopic with 1 conversion to open. Seven patients had a HeartMate II, 2 had Total Artificial Hearts, and 1 had CentriMag. Four patients had devices for ischemic cardiomyopathy and 6 cases were emergent. Surgeries included 6 laparoscopic cholecystectomies, 2 exploratory laparoscopies, 1 laparoscopic colostomy takedown, and 1 laparoscopic ventral hernia repair with mesh. Median age of the patients was 63 years (range, 29-79 years). Median operative time was 123 minutes (range, 30-380 minutes). Five of 10 patients were on preoperative anticoagulation with average intraoperative blood loss of 150 mL (range, 20-700 mL). There were 3 postoperative complications; acute respiratory failure, acute kidney injury and multisystem organ failure resulting in death not related to the surgical procedure. Conclusion. The need for noncardiac surgery in post-MCAD patients is increasing due to limited donors and due to more durable and longer support from newer generation assist devices. While surgery should be approached with caution in this high-risk group, laparoscopic surgery appears to be a safe and successful treatment option.